Dichloromethane → (S)-2-amino-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-3-(tetrahydropyran-2-yl)-propionamide hydrochloride

HRID 19033

Reaktionsgleichung

Reaktionsgleichung von HRID 19033
C(OC(=O)[NH:7][C@H:8]([C:16](=[O:28])[NH:17][C:18]1[CH:22]=[CH:21][N:20]([CH2:23][C:24]([OH:27])([CH3:26])[CH3:25])[N:19]=1)[CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][O:11]1)(C)(C)C.FC(F)(F)C(O)=O.[Cl:37]CCl>>[ClH:37].[NH2:7][C@@H:8]([CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][O:11]1)[C:16]([NH:17][C:18]1[CH:22]=[CH:21][N:20]([CH2:23][C:24]([OH:27])([CH3:25])[CH3:26])[N:19]=1)=[O:28]

Komponenten

4

Versuchsvorschrift

To a solution of [(S)-1-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-ylcarbamoyl]-2-(tetrahydro-pyran-2-yl)-ethyl]-carbamic acid t-butyl ester (570 mg) in dichloromethane (3 mL) was added trifluoroacetic acid (3 mL). The mixture was stirred at room temperature for 30 min. Solvents were evaporated and the residue was dried in vacuo. The waxy solid was dissolved in a methanolic hydrogen chloride solution. Solvents were evaporated and the residue was dried in vacuo. The white solid was triturated with diethyl ether and filtered to afford (S)-2-amino-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-3-(tetrahydropyran-2-yl)-propionamide hydrochloride (529 mg). LR-ES-MS m/z calculated for C15H26N4O3 310 [M]+, observed [M+H]+ 311.

Aufarbeitung

  1. customSolvents were evaporated
  2. customthe residue was dried in vacuo
  3. dissolutionThe waxy solid was dissolved in a methanolic hydrogen chloride solution
  4. customSolvents were evaporated
  5. customthe residue was dried in vacuo
  6. customThe white solid was triturated with diethyl ether
  7. filtrationfiltered

Quellen und Nachweise

ORD-Eintrag
ord-16d60f5e007946408bfde3d22cc2d899
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07741327B2

Verknüpfte Notizen

Wird geladen…